Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pedia...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 52; no. 3; pp. e18 - e55
Main Authors Liu, Catherine, Bayer, Arnold, Cosgrove, Sara E., Daum, Robert S., Fridkin, Scott K., Gorwitz, Rachel J., Kaplan, Sheldon L., Karchmer, Adolf W., Levine, Donald P., Murray, Barbara E., Rybak, Michael J., Talan, David A., Chambers, Henry F.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.02.2011
Subjects
Adolescent
Adult
Adults
Aged
Aged, 80 and over
Anti-Bacterial Agents - therapeutic use
Child
Child, Preschool
Children & youth
Clinical medicine
Humans
Infant
Infant, Newborn
Infectious diseases
Medical treatment
Methicillin-Resistant Staphylococcus aureus - drug effects
Methicillin-Resistant Staphylococcus aureus - isolation & purification
Middle Aged
Staphylococcal Infections - diagnosis
Staphylococcal Infections - drug therapy
Staphylococcal Infections - microbiology
Staphylococcus infections
United States
Vancomycin - therapeutic use
Young Adult
United States
United States > US
Online AccessGet full text

Cover

More Information
Summary:Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciq146